Renovascular hypertension in bradykinin B2-receptor knockout mice

被引:54
|
作者
Madeddu, P
Milia, AF
Salis, MB
Gaspa, L
Gross, W
Lippoldt, A
Emanueli, C
机构
[1] Univ Sassari, Sch Med, I-07100 Sassari, Italy
[2] Univ Sassari, Dept Biol Anim, Pharmacol Sect, I-07100 Sassari, Italy
[3] Natl Inst Biostruct & Biosyst, Natl Lab, Osilo, Italy
[4] Max Delbruck Ctr Mol Med, Dept Nephrol, Berlin, Germany
[5] Ist Dermopat, Dept Vasc Pathol, Rome, Italy
关键词
angiotensin; hypertension; renovascular; mice; kinin B-2-receptor; knockout; hypertrophy; myocardial; kallikrein-kinin system;
D O I
10.1161/01.HYP.32.3.503
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
We evaluated whether kinins exert a protective action against the development of two-kidney, one clip (2K1C) hypertension, a model characterized by an activated renin-angiotensin system in the ischemic kidney and increased expression of the bradykinin (BK) B-2 receptor in the contralateral kidney. BK B-2-receptor knockout (B-2(-/-)), wild-type (B-2(+/+)), and heterozygous (B-2(+/-)) mice underwent clipping of the left renal artery, with the other kidney remaining untouched. Basal systolic blood pressure (SBP, via tail-cuff plethysmography) was higher in B-2(-/-) mice than in B-2(+/-) B-2(+/-) mice (121 +/- 2 versus 113 +/- 2 and 109 +/- 1 mm Hg P<0.05 for both comparisons). SEP did not change from basal values after sham operation, but it increased in mice that underwent clipping. The increase in SEP was greater in 2K1C B-2(-/-) mice than in B-2(+/-) or B-2(+/+) mice (28 +/- 2 versus 14 +/- 2 and 14 +/- 2 mm Hg, respectively, at 2 weeks; P<0.05 for both comparisons). Blockade of the BK B-2 receptor by Icatibant enhanced the pressure response to clipping in B-2(+/+) mice (29 +/- 2 mmHg at 2 weeks). Intra-arterial mean blood pressure (MBP) was higher in 2K1C than in respective sham-operated mice, with the MBP difference being higher in B-2(-/-) mice (32 and 38 mm Hg, at 2 and 4 weeks, respectively), and higher in B-2(+/+) mice given Icatibant (30 and 32 mm Hg) than in B-2(+/+) mice without Icatibant (17 and 18 mm Hg). At 4 weeks, acute injection of an angiotensin type 1 receptor antagonist normalized the MBP of 2K1C hypertensive mice. A tachycardic response was observed 1 week after clipping in B-2(-/-) and B-2(+/-) mice, but this effect was delayed in B-2(+/+) mice. However, the HR response to clipping in B-2(+/+) mice was enhanced by Icatibant, Within each strain, heart weight to body weight ratio was greater in 2K1C hypertensive mice than in sham-operated control animals (B-2(-/-): 5.7 +/- 0.1 versus 5.2 +/- 0.1; B-2(+/+): 5.1 +/- 0.1 versus 4.5 +/- 0.1; P<0.01 for both comparisons). The clipped kidney weight to nonclipped kidney weight ratio was consistently reduced in mice with 2K1C hypertension. Our results indicate that kinins acting on the BK B-2 receptor exert a protective action against excessive blood pressure elevation during early phases of 2K1C hypertension.
引用
收藏
页码:503 / 509
页数:7
相关论文
共 50 条
  • [21] Formulation of 3D-pharmacophore models for bradykinin B2-receptor antagonists
    Pineda, LF
    ZEITSCHRIFT FUR PHYSIKALISCHE CHEMIE-INTERNATIONAL JOURNAL OF RESEARCH IN PHYSICAL CHEMISTRY & CHEMICAL PHYSICS, 1999, 209 : 111 - 131
  • [22] Life-long High Salt Intake Causes Hypertension in Bradykinin B2 Receptor Knockout Mice • 1793
    L Cervenka
    L G Navar
    L M Harrison-Bernard
    S Dipp
    S S El-Dahr
    Pediatric Research, 1998, 43 (Suppl 4) : 306 - 306
  • [23] Novel non-peptide lead structures for Bradykinin B2-receptor antagonists
    Pineda L.F.
    Liebmann C.
    Hensellek S.
    Paegelow I.
    Steinmetzer T.
    Schweinitz A.
    Stürzebecher J.
    Reissmann S.
    Letters in Peptide Science, 2000, 7 (2): : 69 - 77
  • [24] Angiotensin AT1 receptor blockade prevents cardiac hypertrophy and damage but not hypertension in bradykinin B2 receptor knockout mice.
    Madeddu, M
    Emanueli, C
    Maestri, R
    Salis, MB
    Minasi, A
    Capogrossi, M
    Olivetti, G
    HYPERTENSION, 1999, 34 (02) : 331 - 331
  • [25] Formulation of 3D pharmacophore models for bradykinin B2-receptor antagonists
    Pineda, LF
    Hassan, M
    LETTERS IN PEPTIDE SCIENCE, 1998, 5 (2-3): : 189 - 192
  • [26] STRUCTURE-ACTIVITY STUDIES OF BRADYKININ AND RELATED PEPTIDES - B2-RECEPTOR ANTAGONISTS
    RHALEB, NE
    TELEMAQUE, S
    ROUISSI, N
    DION, S
    JUKIC, D
    DRAPEAU, G
    REGOLI, D
    HYPERTENSION, 1991, 17 (01) : 107 - 115
  • [27] Formulation of 3D pharmacophore models for bradykinin B2-receptor antagonists
    L. Felipe Pineda
    Moises Hassan
    Letters in Peptide Science, 1998, 5 : 189 - 192
  • [28] Expression of the bradykinin B2-receptor in human head and neck squamous carcinoma cells
    Kocgirli, O.
    Balz, V.
    Bas, M.
    Kojda, G.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2007, 375 : 22 - 22
  • [29] Novel non-peptide lead structures for Bradykinin B2-receptor antagonists
    Pineda, LF
    Liebmann, C
    Hensellek, S
    Paegelow, I
    Steinmetzer, T
    Schweinitz, A
    Stürzebecher, J
    Reissmann, S
    LETTERS IN PEPTIDE SCIENCE, 2000, 7 (02): : 69 - 77
  • [30] Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant
    Bas, M.
    Bier, H.
    Greve, J.
    Kojda, G.
    Hoffmann, T. K.
    ALLERGY, 2006, 61 (12) : 1490 - 1492